Methyl 6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate, 97%, 250mg

Methyl 4-iodo-1H-pyrazole-3-carboxylate, 95.0%, 25g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 99.0%, 500g

4-Chloro-3-isopropylbenzeneboronic acid, 98%, 250mg

2,2,2-trifluoro-1-pyridin-2-ylethanol, 5g

(4S,4'S)-2,2'-(1,3-Bis(4-(tert-butyl)phenyl)propane-2,2-diyl)bis(4-methyl-4,5-dihydrooxazole), 97%, 1g

Nitrobenzol, min. 98,5 %, zur Synthese, 500 ml, Glasverpackung

2-(Morpholin-2-yl)ethan-1-ol hydrochloride, 98%, 500mg

5-Amino-4-methylnicotinic acid, 95.0%, 500mg

4,6-Dibromothieno[3,4-c]furan-1,3-dione, 95.0%, 5g

2-Chloro-4-fluoro-5-nitrobenzaldehyde, 95.0%, 25g

2-Amino-5-(2-methoxyphenylcarbamoyl)-4-methyl-thiophene-3-carboxylic acid methyl ester, 1g

Enantiomer of Sofosbuvir, 1mg